Press Releases

Press Releases

SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 05/14/12 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, today issued the following letter to its stockholders and the investment community from its CEO, Shawn Singh.
SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 04/25/12 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, has secured a new United States patent covering the company's proprietary methods used to measure and type the toxic
SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 04/16/12 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, has licensed breakthrough stem cell culture technology from the McEwen Centre for Regenerative
Goal to Combine Human Stem Cell-Derived Cardiomyocytes With Novel High-Speed Kinetic Imaging SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 03/21/12 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, and
Goal to Expand VistaGen's Drug Rescue Capabilities Focused on Heart Toxicity SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 03/05/12 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, and Duke University, one of the
Company Identifies Initial Top 10 Candidates for Formal Drug Rescue Programs Beginning in Mid-2012 SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 02/14/12 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy,
VistaGen's Long-Term Relationship With Global Contract Research and Development Organization Expands to Include Right-of-First-Offer for Potential Drug Rescue Candidates SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 02/08/12 -- VistaGen Therapeutics, Inc.
Collaboration to Focus on Leveraging VistaGen's Stem Cell-Based Technology to Develop Safer, Drug Rescue Variants of Once-Promising Drug Candidates SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 12/07/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell
Company Holds Exclusive Worldwide Rights to Intellectual Property Arising From These Discoveries SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 10/25/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces the
SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 10/05/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces a poster presentation of its research and development activities leading to validation of its human
Displaying 251 - 260 of 261